SOPHiA GENETICS Raises $77 Million to Accelerate Democratization of Data-Driven Medicine
SOPHiA GENETICS closes a $77 million investment round led by Generation Investment Management to expand access to data-driven medicine globally.
SOPHiA GENETICS, a health tech company based in Lausanne and Boston, closes a $77 million investment round to accelerate the democratization of data-driven medicine. The funding round is led by Generation Investment Management, with participation from Idinvest Partners and existing investors Balderton Capital and Alychlo.
The company stands out by combining deep expertise in life sciences and medical disciplines with advanced mathematical capabilities. This unique blend of skills allows SOPHiA GENETICS to analyze complex medical data and provide valuable insights for healthcare professionals.
With this new capital injection, SOPHiA GENETICS aims to make data-driven medicine accessible to healthcare institutions worldwide. The company focuses on breaking down barriers so that more patients can benefit from advanced data analytics in their medical care.